Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

ACHC vs CON: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

CON Wins Head-to-Head Institutional Verdict (4–2 across 6 Pillars · 8–2 Matrix Metrics)

CON Overall Winner 6-Pillar Tally: ACHC 2 – 4 CON Matrix Metrics: ACHC 2 – 8 CON

As of Nov 20, 2026, Concentra Group Holdings Parent, Inc. (CON) is the stronger overall head-to-head candidate over Acadia Healthcare Company, Inc. (ACHC) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). ACHC carries a Unified Composite Score of 33.1/100 (SELL) at $34.60 (17.0x Forward P/E, 9.8% operating margin), whereas CON carries 43.5/100 (HOLD) at $41.84 (22.0x Forward P/E, 17.2% operating margin).

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About ACHC vs CON
ACHC NASDAQ
Acadia Healthcare Company, Inc.
Services-Specialty Outpatient Facilities, Nec
$34.60
+0.38% 1D
Market Cap $3.2B
TTM Revenue $3.41B
Forward P/E 17.0x
Beta / 30D Vol 0.68β · 61% Vol
Unified Composite Score
33.1 / 100 SELL
Tech 15.0 Fund 36.0 Flow 59.0 Mom 36.4
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (8.1% over 20 days), RSI 52
RSI-14: 51.8 · SMA20: $34.42 · SMA50: $31.28
CON NYSE Head-to-Head Winner
Concentra Group Holdings Parent, Inc.
Services-Specialty Outpatient Facilities, Nec
$41.84
+0.94% 1D
Market Cap $5.2B
TTM Revenue $2.34B
Forward P/E 22.0x
Beta / 30D Vol 0.52β · 38% Vol
Unified Composite Score
43.5 / 100 HOLD
Tech 31.0 Fund 47.0 Flow 69.0 Mom 41.1
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (8.0% over 20 days), RSI 56
RSI-14: 55.6 · SMA20: $41.80 · SMA50: $38.66

6-Pillar Scorecard Institutional Category Breakdown (ACHC 2 – 4 CON)

Columns: Metric · ACHC · CON
1. Valuation Multiples ACHC
Forward P/E 17.0x 22.0x
Trailing P/E 16.9x 24.5x
PEG Ratio 1.37x N/M
EV / Revenue 1.6x 3.1x
2. Growth & Scale CON
Revenue Growth (YoY) +5.1% +8.6%
Earnings Growth (YoY) -5.1% +36.4%
TTM Revenue (USD) $3.41B $2.34B
Market Cap $3.2B $5.2B
3. Profitability & Quality CON
Gross Margin 41.0% 29.9%
Operating Margin 9.8% 17.2%
Net Profit Margin -33.1% 9.3%
Return on Equity (ROE) -40.5% 47.2%
4. Balance Sheet & Cash Flow CON
Cash Generation (TTM) -$24M $257M
Cash Flow Margin -0.7% 11.0%
Net Cash / Leverage $2.34B Net Debt (1.24x D/E) $2.04B Net Debt (4.20x D/E)
Dividend Yield None (0.00%) 0.60%
5. Options & Positioning CON
Options Structure Phase CONSOLIDATION BREAKOUT
Current IV / %ile 49.8% (31st %ile) 269.9% (95th %ile)
Put/Call OI Skew 0.39x (Call-Skewed) 0.79x (Call-Skewed)
OBV Trend / Tech Phase NEUTRAL · Markup NEUTRAL · Markup
6. R&D & Supply-Chain Moat ACHC
OpEx & R&D Intensity 31.2% of Rev ($1.06B) 12.7% of Rev ($297M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning High-Margin Pricing Power Moat
Supply-Chain Role Medical Care Facilities Operator Medical Care Facilities Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: ACHC (2) vs CON (8)
Institutional Metric ACHC CON Criterion Row Edge
Market Capitalization
Scale
$3.2B $5.2B Larger Scale CON
Trailing P/E Ratio
Valuation
16.9x 24.5x Lower Multiple ACHC
Forward P/E Ratio
Valuation
17.0x 22.0x Lower Multiple ACHC
Revenue Growth (YoY)
Growth
+5.1% +8.6% Higher Growth CON
Operating Margin (TTM)
Profitability
9.8% 17.2% Higher Margin CON
Net Profit Margin
Profitability
-33.1% 9.3% Higher Margin CON
Return on Equity (ROE)
Capital Efficiency
-40.5% 47.2% Higher ROE CON
52-Week Range Position
Momentum
82% ($11–$40) 91% ($19–$44) Stronger Trend CON
Beta / 30D Volatility
Risk Regime
0.68β · 61% Vol 0.52β · 38% Vol Lower Realized Risk CON
Unified Institutional Score
Composite Signal
33.1 / 100 (SELL) 43.5 / 100 (HOLD) Higher Composite CON
Trailing 12M Revenue (USD)
Operating Scale
$3.41B $2.34B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
41.0% 29.9% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
1.37x PEG · 1.6x EV/Rev N/M PEG · 3.1x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
-$24M ($2.34B Net Debt (1.24x D/E)) $257M ($2.04B Net Debt (4.20x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon ACHC +3.85 pp
ACHC: +8.53% · CON: +4.68%
3M Horizon ACHC +0.89 pp
ACHC: +20.47% · CON: +19.58%
6M Horizon CON +15.97 pp
ACHC: +49.27% · CON: +65.24%
1Y Horizon ACHC +23.7 pp
ACHC: +141.28% · CON: +117.58%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period ACHC Revenue CON Revenue ACHC Op. Margin CON Op. Margin Margin Leader
FY2018 $1.90B N/A 31.2% N/A ACHC
FY2019 $2.01B N/A 29.2% N/A ACHC
FY2020 $2.09B N/A -32.2% N/A ACHC
FY2021 $2.31B N/A 8.2% N/A ACHC
FY2022 $2.61B $1.72B 10.5% 15.0% CON
FY2023 $2.93B $1.84B -0.7% 15.6% CON
FY2024 $3.15B $1.90B 8.1% 16.0% CON
FY2025 $3.31B $2.16B -33.3% 15.4% CON

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
ACHC CONSOLIDATION
87d in phase · OBV NEUTRAL
Current IV 49.8%
IV Percentile 31st %ile
Put/Call OI Skew 0.39x (Call-Skewed)
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BEARISH
OBV Flow NEUTRAL
Exact ACHC Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
CON BREAKOUT
99d in phase · OBV NEUTRAL
Current IV 269.9%
IV Percentile 95th %ile
Put/Call OI Skew 0.79x (Call-Skewed)
IV Regime Extreme (>80th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow NEUTRAL
Exact CON Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
LIVE OPTIONS CHAIN · T+5 TRADING DAY HORIZON Spot $38.10 · IV 47.7%

ACHC Simulated 5-Day Option Payoffs vs. Owning 100 Shares ($3,810)

Compare $3,810 in 100-share capital outlay against risk-defined 5-day vertical spreads, put-wall income, and 3-leg structures at 47.7% ATM IV.

PUT-WALL MONTHLY INCOME Liq C

Jan 15 '27 $35 / $30 Bull Put Spread

Sell 1x $35P · Buy 1x $30P · 59d

Net Entry $112 Credit
Max Credit / Yield +$112 (+28.9% RoM)
Max Risk / Buffer -11.1% Cushion ($388 Mgn)
5d Edge & Liquidity 71% PoP · Liq C
Simulate 5-Day Payoff →
5-DAY DOWNSIDE SPREAD Liq C

Dec 18 $40 / $35 Bear Put Spread

Buy 1x $40P · Sell 1x $35P · 31d

Net Entry $220 Debit
T+5d @ -5% Drop +$73 (+33%)
Max Risk / Buffer $220 Capped
5d Edge & Liquidity 0.9x R:R · Liq C
Simulate 5-Day Payoff →

Simulated T+5 trading day payoffs use live option midpoints, bid-ask spread adjustments, and implied volatility skew for educational scenario modeling only — not personalized investment advice. Options involve substantial risk.

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
ACHC Moat Profile Cyclical / Execution-Driven Positioning
Medical Care Facilities Operator
Competes within the Medical Care Facilities value chain with $3.2B market capitalization and 9.8% operating margin.
OpEx & R&D Reinvestment 31.2% of Rev ($1.06B)
90D Engineering Disclosures 0 Published
CON Moat Profile High-Margin Pricing Power Moat
Medical Care Facilities Operator
Competes within the Medical Care Facilities value chain with $5.2B market capitalization and 17.2% operating margin.
OpEx & R&D Reinvestment 12.7% of Rev ($297M)
90D Engineering Disclosures 0 Published

Investor FAQ ACHC vs CON Key Questions & Quantitative Answers

As of Nov 20, 2026, Concentra Group Holdings Parent, Inc. (CON) is the stronger overall head-to-head candidate over Acadia Healthcare Company, Inc. (ACHC) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). ACHC carries a Unified Composite Score of 33.1/100 (SELL) at $34.60 (17.0x Forward P/E, 9.8% operating margin), whereas CON carries 43.5/100 (HOLD) at $41.84 (22.0x Forward P/E, 17.2% operating margin). Technically, ACHC sits in a Markup phase (RSI 51.8, CONSOLIDATION options structure) and CON sits in a Markup phase (RSI 55.6, BREAKOUT options structure).

CON leads the Growth & Scale pillar: ACHC posts +5.1% YoY revenue growth and -5.1% YoY earnings growth on $3.41B TTM revenue (41.0% gross margin, 9.8% operating margin), compared with CON at +8.6% YoY revenue growth and +36.4% YoY earnings growth on $2.34B TTM revenue (29.9% gross margin, 17.2% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), ACHC cumulative revenue shifted +74.2% while CON shifted +25.6%. In operating R&D and SG&A reinvestment, ACHC deploys 31.2% of Rev ($1.06B) (0 90-day corporate R&D disclosures) versus 12.7% of Rev ($297M) (0 disclosures) for CON.

ACHC screens cheaper on headline valuation multiples. ACHC trades at 17.0x Forward P/E, 16.9x Trailing P/E, 1.37x PEG, and 1.6x EV/Revenue (-0.7% FCF margin), whereas CON trades at 22.0x Forward P/E, 24.5x Trailing P/E, N/M PEG, and 3.1x EV/Revenue (11.0% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ACHC (-40.5% ROE) versus CON (47.2% ROE) capital efficiency.

In options market volatility and institutional positioning, ACHC carries 49.8% implied volatility (31st %ile, Balanced (25th–60th %ile)), a 0.39x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a CONSOLIDATION options structure phase (0.68β · 61% Vol realized risk). By comparison, CON carries 269.9% implied volatility (95th %ile, Extreme (>80th %ile)), a 0.79x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a BREAKOUT options structure phase (0.52β · 38% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.